Minerva Neurosciences Inc
(NASDAQ : NERV)

( )
NERV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.89%179.941.2%$613.29m
CELGCelgene Corporation
1.37%77.661.2%$573.03m
GILDGilead Sciences, Inc.
0.50%68.170.9%$553.71m
BIIBBiogen Inc.
1.45%283.751.2%$528.19m
REGNRegeneron Pharmaceuticals, Inc.
0.21%295.312.6%$309.20m
ILMNIllumina, Inc.
0.34%271.733.5%$236.17m
VRTXVertex Pharmaceuticals Incorporated
0.45%156.981.9%$231.45m
ALXNAlexion Pharmaceuticals, Inc.
-0.74%118.132.0%$223.26m
AAgilent Technologies, Inc.
-0.48%64.531.5%$209.75m
NKTRNektar Therapeutics
1.04%82.806.0%$200.36m
INCYIncyte Corporation
0.02%66.572.5%$176.67m
SRPTSarepta Therapeutics, Inc.
-0.29%88.9616.6%$124.64m
BMRNBioMarin Pharmaceutical Inc.
0.97%88.464.4%$118.47m
EXASExact Sciences Corporation
-3.10%51.3525.5%$112.48m
BLUEBluebird Bio, Inc.
2.02%189.4015.7%$96.63m

Company Profile

Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company's product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.